Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
GPCR
GPCR News & Events
-
Add to Watchlist
Trade GPCR Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
GPCR News
Truist Initiates Coverage on VKTX with Buy Rating and $83 Price Target
2d ago
stocktwits
Deep Track Capital Increases Stake in Structure Therapeutics
6d ago
Fool
Deep Track Capital Increases Stake in Structure Therapeutics
6d ago
NASDAQ.COM
Monashee Reduces Stake in Structure Therapeutics Amid Competitive Landscape
May 20 2026
Fool
HighVista Strategies Sells Shares of Structure Therapeutics
May 17 2026
Fool
ACT Capital Management Fully Exits Structure Therapeutics Stake
May 10 2026
Fool
Analyst Reiterates Strong Buy Rating for VKTX Ahead of Earnings
Apr 28 2026
stocktwits
Viking Therapeutics Q1 Earnings Preview Highlights Losses and Market Potential
Apr 22 2026
stocktwits
Show More News
GPCR Events
04/14 16:20
Structure Therapeutics Appoints Matthew Lang as COO and General Counsel
Structure Therapeutics announced the appointment of Matthew Lang as COO and general counsel. Lang most recently served as chief legal officer and secretary at Metsera.
Show More Events
GPCR Monitor News
Structure Therapeutics seen as potential acquisition target amid market decline
Feb 03 2026
Structure Therapeutics Reports Positive Phase 2 Data for Aleniglipron
Jan 14 2026
Structure Therapeutics Reports Positive Phase 2 Data for Aleniglipron
Jan 13 2026
Structure Therapeutics Inc. rises on market strength
Dec 23 2025
Structure Therapeutics Inc Hits 52-Week High on Positive Trial Data
Dec 08 2025
GPCR Hits 52-Week High Amid Positive Analyst Outlook
Nov 19 2025
GPCR.O Surges Past 5-Day SMA Amid Positive Sentiment
Nov 14 2025
GPCR Earnings Analysis
No Data
People Also Watch
